21 citations
,
October 2009 in “Dermatology” This study found that male pattern hair loss may be associated with differences in serum levels of androstenedione, cortisol, 17 beta-estradiol, and luteinizing hormone, compared to controls.
April 2026 in “The Journal of Urology” This study found that prolonged use of finasteride and dutasteride in young men with androgenic alopecia is linked to a decline in semen quality over time, particularly affecting sperm motility and DNA integrity, with dutasteride showing a slightly greater impact than finasteride.
March 2025 in “Daehan saengsik uihak hoeji/Clinical and experimental reproductive medicine” This study found that long-term use of dutasteride in men taking it for androgenetic alopecia may lead to persistent decreases in semen volume and sperm motility, potentially impacting fertility, with significant impairment observed after 17.8 to 20.3 months of treatment.
January 2004 in “Journal of Clinical Dermatology” This study found significant differences in serum total lipid, phospholipid, and triglyceride levels between patients with androgenetic alopecia and those without but no differences in LDL, HDL, or total cholesterol.
September 2023 in “Journal of the turkish academy of dermatology” In this study, researchers found that men with androgenetic alopecia had higher obesity-related parameters, such as fat percentage and BMI, compared to healthy controls, but observed no differences in cardiovascular markers like CIMT and EFT.